Scientific and Clinical Advisory Council
SafeMinds Scientific & Clinical Advisory Council is comprised of clinicians, health professionals, and scientists from a variety of disciplines, including, among others, specialists and experts in autism, environment, toxicology, pediatrics, neuroscience, pharmacology, and psychology.
José G. Dórea, Ph.D.
Professor of Nutritional Sciences, University of Brasília
A graduate of the University of Pernambuco with advanced degrees from the University of Massachusetts (MSc and PhD), Dr. Dorea has worked at Iowa State University (USA), University of Hawaii (USA), and University of Campinas (Brazil). He has authored numerous book chapters, and has published on infant nutrition and the environmental impact of toxic (natural and man made) substances on the growth and development of children. Dr. Dorea is on the editorial board of peer-reviewed scientific journals, and has authored and co-authored more than 180 papers in journals of public health, medical and environmental sciences, toxicology, and pharmacology.
Cindy Schneider, MD
Medical Director, Center for Autism Research and Education
Dr. Schneider is the Medical Director of CARE, the Center for Autism Research and Education. Her integrative medical practice is exclusively dedicated to individuals with autism and related neurological and immune disorders. Dr. Schneider’s areas of special interest include treatment of the immune, gastrointestinal, and metabolic aspects of autism and the identification of environmental toxins contributing to the autism epidemic. She has designed and implemented multiple research studies, and collaborated with researchers worldwide. Dr. Schneider’s priorities in both her medical practice and her research include the identification of the causes of autism, the formulation of effective treatment protocols, and the prevention of autism in future generations.
Dr. Schneider has served as a member of the Defeat Autism Now! think tank since 1997, and serves on the Clinician Advisory Committee at the Autism Research Institute. She was the founding president and medical director of two nonprofit organizations for autism research, and is a medical advisor for SafeMinds. Dr. Schneider has published extensively in the areas of genetic vulnerability to environmental toxins, and innovative treatments for the gastrointestinal and immune complications of autism.
As the mother of two children with autism and a leading authority in the field, Dr. Schneider closely tracks developments in autism research, and provides both a medical and personal assessment of current and promising treatment options.
Robert Sears, M.D.
Robert W. Sears, MD, FAAP, is a board-certified pediatrician in a full-time private practice in Dana Point, Calif. He received his medical degree from Georgetown University, and did his pediatric residency training at Childrens Hospital Los Angeles. “Dr. Bob,” as he likes to be called by his little patients, provides a unique blend of mainstream and integrative medical care. He is a co-author in the Sears Parenting Library, including The Baby Book and The Portable Pediatrician, and is the author of The Vaccine Book, The Autism Book, and HappyBaby: The Organic Guide to Baby’s First 24 Months. Dr. Bob has appeared on Dr. Oz, The Doctors, CNN, CBS Early Show, Fox Morning News, and Dr. Phil discussg parenting advice and pediatric health issues. He is a frequent speaker at parenting conferences, and serves on the medical advisory board for various organizations, including Talk About Curing Autism, Autism Care and Treatment Today, HappyBaby Organic Baby Food, and Kaplan University Department of Health Sciences. Dr. Bob is a contributor to AskDrSears.com, and regularly answers questions on his Mothering.com Ask the Experts forum.
COVID-19 Shuts Down Portions of Important Autism Research
Scientists Adapt to Changes in the Workplace: In mid-March, Spectrum Autism Research News alerted the autism community to a troubling new problem with potentially long-term consequences. Due to the COVID-19 pandemic, scientists across the nation began to scramble figuring out ways to either continue or alter their research projects as colleges and universities were shutting down, sending their students home in order to transition to remote learning. These actions, intended to slow the spread of COVID-19, established situations where autism research was either halted or hindered, setting back promising projects including clinical trials.
Is Disclosing an Autism Diagnosis a Good Idea? There’s No Clear Answer
Results are mixed when it comes to disclosing a child’s autism diagnosis to other people. Generally, being transparent about the disorder is considered a good idea. However as a researcher at the University of Alberta (U of A) has found, it doesn’t always point to better inclusion or reduced bullying. Unfortunately, in some instances, the admission can lead to reduced expectations at school and an obstacle to participating in team sports.
Maryland Legislation Requires Phase Out of Toxic Pesticide Tied to Autism
A bill requiring a ban on the insecticide chlorpyrifos passed both legislative houses1 in Maryland. Maryland joins other states 2 including California, New Jersey, Connecticut and Oregon with plans to forbid the substance. The state bans are welcome news for future children since chlorpyrifos has been linked to lower IQ and neurodevelopmental issues, including autism.
Positive Results from a Microbiome Treatment Trial for Autism
Results of a novel microbial-inspired drug study look promising at reducing the core symptoms of autism. Adolescents with the condition had lowered scores on irritability, anxiety and social withdrawal while on the medication. The drug, called AB-2004, works on the gut-brain axis. Communication between the bacteria in the gut and the brain impacts the way the brain develops and functions as well as behavior.
Tools From UNC & ARI to Support Individuals with Autism During COVID-19
With more than 90% of all Americans currently under stay at home orders due to COVID-19, families are rapidly adapting to a highly unusual way of living. Almost everyone’s schedule has been disrupted. Students are now attending classes over the internet. Parents are working from home. Gym classes and social engagements take place over Zoom. Even medical appointments are occurring remotely through telehealth and telemedicine technology.
Robots Could Improve Socialization Skills for Children with Autism
A small robot, shaped like a bird, is perched on a desk in front of a child with autism spectrum disorder (ASD). While the child plays math games on a tablet, the friendly bird provides instruction and feedback–essentially coaching the child until each computer game is completed. This scenario is not a new plot line from an upcoming science fiction film.
